Table 3.

Post-TAVR outcomes stratified by the presence or absence of CXRT

Post-TAVR outcomes	CXRT	Non-CXRT	P value
All-cause mortality, %	25.6	9.2	0.009*
MACE, %	55.81	19.86	< 0.0001*
CV mortality, %	18.6	2.84	0.001*

(*) p-value is significant. MACE major adverse cardiac events, CV cardiovascular